CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine

The Pharmacogenomics Journal
Reinhold KreutzJoachim Beige

Abstract

The CYP3A5*1 allele has been linked to high expression of CYP3A5 and metabolism of cyclosporine. We evaluated the role of CYP3A5*1 for long-term survival in renal transplant patients in a cohort of 399 patients who underwent cadaveric or living donor kidney allograft transplantation. All patients were treated with a similar cyclosporine-based immunosuppressive maintenance therapy protocol. The mean duration of follow-up was 8.6+/-3.7 years. In univariate survival analysis, the presence of the CYP3A5*1 allele in recipients significantly increased patient survival P=0.028 (log-rank), resulting in a hazard ratio (HR) of 0.52 (95% CI=0.29-0.94). When the presence of the CYP3A5*1 allele was included in multivariate Cox regression analyses accounting for major risk factors for patient death, CYP3A5*1 still conferred a protective effect. Further, haplotype analysis at the CYP3A5 locus confirmed that CYP3A5*1 might indeed be responsible for this survival benefit.

References

Dec 1, 1995·Clinical Biochemistry·U Christians, K F Sewing
Jan 11, 2000·Clinical Pharmacokinetics·S N de WildtJ N van den Anker
Mar 7, 2001·Nature Medicine·M Eichelbaum, O Burk
Jun 18, 2002·Molecular Pharmacology·Yvonne S LinKenneth E Thummel
Jul 19, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·J Andrew WilliamsSteven A Wrighton
May 20, 2003·Journal of Applied Physiology·Raymond C GivensPaul B Watkins
Mar 26, 2004·Transplantation Proceedings·R Calne
May 29, 2004·Pharmacogenetics·Kenneth E Thummel
Jul 2, 2004·Therapeutic Drug Monitoring·Leszek Wojnowski
Sep 29, 2004·Biochemical Pharmacology·Yang DaiKenneth E Thummel
Mar 18, 2005·Journal of the American Society of Nephrology : JASN·Ingeborg A HauserMatthias Schwab
Jul 26, 2005·Pharmacogenetics and Genomics·Sarah C SimMagnus Ingelman-Sundberg
Sep 21, 2005·Biochemical and Biophysical Research Communications·Cristina Rodríguez-AntonaMagnus Ingelman-Sundberg
Oct 14, 2005·Kidney International·Femke van der Sman-de BeerUNKNOWN NECOSAD Study Group
Nov 30, 2005·The Pharmacogenomics Journal·E E ThompsonA Di Rienzo
Jul 27, 2006·Expert Opinion on Drug Metabolism & Toxicology·Leszek Wojnowski, Landry K Kamdem
Oct 18, 2006·Clinical and Experimental Pharmacology & Physiology·Yong-Fang HuHong-Hao Zhou
Oct 20, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·V HaufroidM Mourad

❮ Previous
Next ❯

Citations

Dec 13, 1997·Biochimica Et Biophysica Acta·Z WieczorekR Stolarski
Oct 16, 2012·Journal of the American Society of Nephrology : JASN·Jason MooreRichard Borrows
Feb 9, 2010·Pharmacogenomics·Gilbert J Burckart, Shashi Amur
Nov 30, 2012·Molecular Diagnosis & Therapy·Laure ElensTeun van Gelder
Jun 24, 2010·Therapeutic Drug Monitoring·Dennis A HesselinkTeun van Gelder
Dec 9, 2009·Expert Opinion on Drug Metabolism & Toxicology·Minoli A Perera
Nov 1, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Iain A M MacPhee
Oct 16, 2015·Therapeutic Drug Monitoring·Nicolas PicardVincent Haufroid

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.